Information Provided By:
Fly News Breaks for October 13, 2015
THOR, STJ, HTWR
Oct 13, 2015 | 08:33 EDT
Oppenheimer analyst Steven Lichtman downgraded HeartWare (HTWR) to Perform citing another potential delay in the CE Mark trial for the company's next-generation MVAD. The delay puts an overhang on HeartWare shares given the progress St. Jude Medical's (STJ) Thoratec has made with their next-generation HeartMate III, Lichtman tells investors in a research note.
News For HTWR;STJ;THOR From the Last 2 Days
There are no results for your query HTWR;STJ;THOR